Transcriptionally regulated adenoviruses for prostate-specific gene therapy Yi LuMitchell S. Steiner Pages: 93 - 101
Osteocalcin-directed gene therapy for prostate-cancer bone metastasis Kenneth S. KoenemanChinghai KaoThomas A. Gardner Pages: 102 - 110
Adenovirus p16 gene therapy for prostate cancer James A. AllayMitchell S. SteinerYi Lu Pages: 111 - 120
Ad5CMVp53 gene therapy for locally advanced prostate cancer – where do we stand? Paul SweeneyLouis L. Pisters Pages: 121 - 124
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene Moshe ShalevBrian J. MilesDov Kadmon Pages: 125 - 129
Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer Waleed HassanMichael A. SanfordSimon J. Hall Pages: 130 - 135
Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development Linda G. CharlesYilin C. XieMartin G. Sanda Pages: 136 - 142
Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions Allan J. PantuckAmnon ZismanArie S. Belldegrun Pages: 143 - 147
Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex David M. J. HoffmanRobert A. Figlin Pages: 152 - 156
B7-1 gene-modified autologous tumor-cell vaccines for renal-cell carcinoma Scott J. AntoniaJohn D. Seigne Pages: 157 - 163